Literature DB >> 28557437

Differentiating Physicochemical Properties between Addictive and Nonaddictive ADHD Drugs Revealed by Molecular Dynamics Simulation Studies.

Panpan Wang1,2, Xiaoyu Zhang2, Tingting Fu2, Shuang Li2, Bo Li2, Weiwei Xue2, Xiaojun Yao3, Yuzong Chen4, Feng Zhu1,2.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed mental disorder of children and adolescents. Although psychostimulants are currently the first-line drugs for ADHD, their highly addictive profile raises great abuse concerns. It is known that psychostimulants' addictiveness is largely attributed to their interaction with dopamine transporter (DAT) and their binding modes in DAT can thus facilitate the understanding of the mechanism underlining drugs' addictiveness. However, no DAT residue able to discriminate ADHD drugs' addictiveness is identified, and the way how different drug structures affect their abuse liability is still elusive. In this study, multiple computational methods were integrated to differentiate binding modes between approved psychostimulants and ADHD drugs of little addictiveness. As a result, variation in energy contribution of 8 residues between addictive and nonaddictive drugs was observed, and a reduction in hydrophobicity of drugs' 2 functional groups was identified as the indicator of drugs' addictiveness. This finding agreed well with the physicochemical properties of 8 officially reported controlled substances. The identified variations in binding mode can shed light on the mechanism underlining drugs' addictiveness, which may thus facilitate the discovery of improved ADHD therapeutics with reduced addictive profile.

Entities:  

Keywords:  ADHD drug; abuse potential; addictive profile; molecular dynamics; psychostimulants

Mesh:

Substances:

Year:  2017        PMID: 28557437     DOI: 10.1021/acschemneuro.7b00173

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  18 in total

1.  Protein functional annotation of simultaneously improved stability, accuracy and false discovery rate achieved by a sequence-based deep learning.

Authors:  Jiajun Hong; Yongchao Luo; Yang Zhang; Junbiao Ying; Weiwei Xue; Tian Xie; Lin Tao; Feng Zhu
Journal:  Brief Bioinform       Date:  2020-07-15       Impact factor: 11.622

2.  Identification of novel immune-relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis.

Authors:  Zhi-Jie Han; Wei-Wei Xue; Lin Tao; Feng Zhu
Journal:  CNS Neurosci Ther       Date:  2018-08-14       Impact factor: 5.243

3.  Effects of the N-terminal dynamics on the conformational states of human dopamine transporter.

Authors:  Liang Xu; Liao Y Chen
Journal:  Biophys Chem       Date:  2022-01-25       Impact factor: 2.352

4.  Effects of stimulant medication on divergent and convergent thinking tasks related to creativity in adults with attention-deficit hyperactivity disorder.

Authors:  Molly McBride; Carrina Appling; Bradley Ferguson; Alyssia Gonzalez; Andrea Schaeffer; Amanda Zand; David Wang; Alinna Sam; Eric Hart; Aneesh Tosh; Ivan Fontcha; Sophia Parmacek; David Beversdorf
Journal:  Psychopharmacology (Berl)       Date:  2021-09-03       Impact factor: 4.530

5.  Association of sigma-1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix-helix interactions.

Authors:  Liang Xu; Liao Y Chen
Journal:  Chem Biol Drug Des       Date:  2021-04-04       Impact factor: 2.873

6.  Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors.

Authors:  Ting-Ting Fu; Gao Tu; Meng Ping; Guo-Xun Zheng; Feng-Yuan Yang; Jing-Yi Yang; Yang Zhang; Xiao-Jun Yao; Wei-Wei Xue; Feng Zhu
Journal:  Acta Pharmacol Sin       Date:  2020-10-29       Impact factor: 7.169

7.  Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.

Authors:  Ying Hong Li; Chun Yan Yu; Xiao Xu Li; Peng Zhang; Jing Tang; Qingxia Yang; Tingting Fu; Xiaoyu Zhang; Xuejiao Cui; Gao Tu; Yang Zhang; Shuang Li; Fengyuan Yang; Qiu Sun; Chu Qin; Xian Zeng; Zhe Chen; Yu Zong Chen; Feng Zhu
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

8.  Assessing the Performances of Protein Function Prediction Algorithms from the Perspectives of Identification Accuracy and False Discovery Rate.

Authors:  Chun Yan Yu; Xiao Xu Li; Hong Yang; Ying Hong Li; Wei Wei Xue; Yu Zong Chen; Lin Tao; Feng Zhu
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

9.  Discovery of the Consistently Well-Performed Analysis Chain for SWATH-MS Based Pharmacoproteomic Quantification.

Authors:  Jianbo Fu; Jing Tang; Yunxia Wang; Xuejiao Cui; Qingxia Yang; Jiajun Hong; Xiaoxu Li; Shuang Li; Yuzong Chen; Weiwei Xue; Feng Zhu
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

10.  Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.

Authors:  Ying Hong Li; Xiao Xu Li; Jia Jun Hong; Yun Xia Wang; Jian Bo Fu; Hong Yang; Chun Yan Yu; Feng Cheng Li; Jie Hu; Wei Wei Xue; Yu Yang Jiang; Yu Zong Chen; Feng Zhu
Journal:  Brief Bioinform       Date:  2020-03-23       Impact factor: 11.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.